Remedy_label (Remedy Label)
Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 70518-2532
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 70518-2532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)
This text appears to provide information related to drug interactions and recommendations for usage. It mentions the interaction of a drug called "cimetane" with an analyte called "aniatxine" and provides PK Fold Change and 90% CI Recommendation. It also recommends using caution and monitoring blood pressure when using these drugs, particularly in patients with hypertension or hepatic dysfunction. The text does not provide any further information about the drugs or their usage.*
Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)
Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)
Chemical Structure (Venlafaxine Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
